Shanghai Fosun Pharma, a research and marketing partner of BioNTech with the exclusive right to supply the latter’s mRNA vaccine to mainland China, Hong Kong, Macau and Taiwan, has also applied to China’s drug regulator to import the drug from Germany, with localized bottling and packing being planned.
Gao and other CDC experts told CCTV last week that there would be a “quick turnaround” from regulators for new drugs and formulas proven to be effective overseas to enter China and help battle any viral resurgences.
asiatimes.com/2021/08/...to-launch-locally-made-mrna-vaccine/